31,400 Shares in MetLife, Inc. $MET Bought by Andra AP fonden

Andra AP fonden purchased a new position in MetLife, Inc. (NYSE:MET) during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 31,400 shares of the financial services provider’s stock, valued at approximately $2,221,000.

Other institutional investors also recently bought and sold shares of the company. Activest Wealth Management lifted its holdings in MetLife by 205.8% during the fourth quarter. Activest Wealth Management now owns 315 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 212 shares in the last quarter. Sound Income Strategies LLC boosted its stake in MetLife by 58.9% during the 4th quarter. Sound Income Strategies LLC now owns 383 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 142 shares during the last quarter. Garton & Associates Financial Advisors LLC purchased a new stake in shares of MetLife during the fourth quarter worth $30,000. Gunpowder Capital Management LLC dba Oliver Wealth Management purchased a new position in shares of MetLife in the fourth quarter worth about $31,000. Finally, Prosperity Bancshares Inc purchased a new position in MetLife in the 4th quarter worth approximately $31,000. 94.99% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

MET has been the topic of several recent analyst reports. Jefferies Financial Group boosted their target price on shares of MetLife from $97.00 to $103.00 and gave the company a “buy” rating in a report on Friday, July 10th. Weiss Ratings raised MetLife from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, June 15th. TD Cowen raised their price target on MetLife from $87.00 to $105.00 and gave the company a “buy” rating in a research note on Wednesday. Bank of America dropped their price target on shares of MetLife from $103.00 to $99.00 and set a “buy” rating on the stock in a research note on Tuesday, April 14th. Finally, UBS Group raised their price objective on shares of MetLife from $102.00 to $105.00 and gave the stock a “buy” rating in a report on Wednesday, July 8th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $100.50.

MetLife Stock Performance

NYSE MET opened at $92.65 on Friday. MetLife, Inc. has a 52-week low of $67.33 and a 52-week high of $94.86. The business’s 50-day moving average price is $86.97 and its 200 day moving average price is $79.45. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.53. The firm has a market cap of $59.61 billion, a P/E ratio of 17.95, a P/E/G ratio of 0.71 and a beta of 0.78.

MetLife (NYSE:MET) last released its earnings results on Wednesday, May 6th. The financial services provider reported $2.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.15. MetLife had a return on equity of 22.60% and a net margin of 4.66%.The business had revenue of $14.18 billion for the quarter, compared to analyst estimates of $19.49 billion. During the same quarter in the previous year, the company posted $1.96 earnings per share. The company’s revenue for the quarter was up 2.7% compared to the same quarter last year. On average, equities research analysts expect that MetLife, Inc. will post 9.94 earnings per share for the current year.

MetLife Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 8th. Stockholders of record on Tuesday, August 4th will be paid a dividend of $0.5925 per share. This represents a $2.37 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date is Tuesday, August 4th. MetLife’s payout ratio is 45.93%.

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.